Excellent
Mostly Aligned
Patient Risk:
Low
Summary
The evaluated claim about abuse/misuse/addiction and overdose/death risk—along with increased risk at higher doses and unapproved administration such as snorting or injection—is directly supported by the provided FDA label (Boxed Warning, Sections 5.1, 9.2, and 10).
Category Scores
Accurate Statements
Abuse/misuse/addiction risk is high and misuse/abuse can lead to overdose and death.
Supported by Boxed Warning (ABUSE, MISUSE, AND ADDICTION) and Sections 5.1 (Abuse, Misuse, and Addiction) and 9.2 (Abuse).
The risk is increased at higher doses.
Supported by Boxed Warning and Sections 5.1 and 9.2.
Unapproved administration methods such as snorting or injection increase risk.
Supported by Boxed Warning and Sections 5.1 and 9.2 (explicitly cites snorting or injection).
Overdose is serious (overdose outcomes described in the label).
Supported by Section 10 (Overdosage) describing life-threatening effects (e.g., cardiovascular and CNS effects).
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
No contradictions or unsupported safety claims were identified for the evaluated statement; the claim aligns with the label’s abuse/misuse and overdose risk messaging.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Suggested Improvement